Sulfacetamide sodium + Prednisolone sodium phosphate Ophthalmic Solution Rx
Generic Name and Formulations:
Sulfacetamide sodium 100mg, prednisolone sodium phosphate 2.5mg; per mL; contains thimersol.
Various generic manufacturers
Indications for Sulfacetamide sodium + Prednisolone sodium phosphate Ophthalmic Solution:
For steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial ocular infection exists.
Adults and Children:
<6yrs: not established. ≥6yrs: instill 2 drops in the eye(s) every 4 hours. Max initial ℞: 20mL.
Ocular fungal, viral or mycobacterial infections.
Do not inject into the eye. Corneal or scleral thinning. Severe dry eye. Glaucoma. Monitor IOP, and for secondary infections in prolonged use. Discontinue if sensitization reaction occurs. Reevaluate if symptoms fail to improve after two days. Pregnancy (Cat.C). Nursing mothers: not recommended.
Antibacterial + steroid.
Incompatible with silver preparations. Local anesthetics related to p-aminobenzoic acid may antagonize the action of sulfonamide.
Local irritation, sensitization, masks infection, delays healing; in prolonged use: increased IOP, cataracts, corneal perforation, optic nerve damage.
Formerly known under the brand name Vasocidin.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- Managing Immune-Related Adverse Events
- PD-1/PD-L1 Inhibitors May Increase the Risk of Hyperprogressive Disease in NSCLC
- Predicting Response to Immunotherapy in Late-Stage Melanoma
- Genetic Counseling Recommended for Advanced Prostate Cancer
- Feasibility of Clinical Production of Autologous NKG2D CAR-T
- BRCA1/Shieldin Double Mutations May Signal Resistance to PARP Inhibitors
- Transplant Status May Affect CAR-T Therapy Outcomes in CLL and B-ALL
- Study Zeroes in on Cause of Castration-Resistant Prostate Cancer
- Beyond BRCA: New Predisposition Genes Linked to Breast, Ovarian Cancers